Discovery of BILN 2061 -: A small molecule inhibitor of the hepatitis C virus serine protease.

被引：0

作者：

Llinàs-Brunet, M ^{[1
]}

Bailey, M ^{[1
]}

Bolger, G ^{[1
]}

Cameron, D ^{[1
]}

Cartier, M ^{[1
]}

Faucher, AM ^{[1
]}

Goudreau, N ^{[1
]}

Kukolj, G ^{[1
]}

Lagacé, L ^{[1
]}

Pause, A ^{[1
]}

Rancourt, J ^{[1
]}

Thibeault, D ^{[1
]}

Tsantrizos, Y ^{[1
]}

Lamarre, D ^{[1
]}

机构：

[1] Boehringer Ingelheim Canada Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 225卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

320-MEDI

引用

页码：U231 / U231

页数：1

共 50 条

[41] Bleomycin is a potent small molecule inhibitor of hepatitis C virus replication
Rakic, Bojana
Brulotte, Marc
Pezacki, John Paul
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 856 - 856
[42] Small-molecule modulators of serine protease inhibitor proteins (serpins)
Kellici, Tahsin F.
Pilka, Ewa S.
Bodkin, Michael J.
DRUG DISCOVERY TODAY, 2021, 26 (02) : 442 - 454
[43] ASUNAPREVIR HCV Serine Protease NS3 Inhibitor Treatment of Hepatitis C Virus
Reviriego, C.
DRUGS OF THE FUTURE, 2012, 37 (04) : 247 - 254
[44] Safety, tolerability and antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C genotype 1, with advanced liver fibrosis.
Benhamou, Y
Hinrichsen, H
Sentjens, R
Reiser, M
Manns, MP
Forns, X
Avendano, C
Crönlein, J
Nehmiz, G
Steinmann, G
HEPATOLOGY, 2002, 36 (04) : 304A - 304A
[45] Hepatitis C virus NS3 serine protease interacts with the serpin Cl inhibitor
Drouet, C
Bouillet, L
Csopaki, F
Colomb, MG
FEBS LETTERS, 1999, 458 (03) : 415 - 418
[46] Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease
Duan, Maosheng
Kazmierski, Wieslaw
Crosby, Renae
Gartland, Margaret
Ji, Jinjing
Tallant, Matt
Wang, Amy
Hamatake, Robert
Wright, Lois
Wu, Min
Zhang, Yong-Kang
Ding, Charles Z.
Li, Xianfeng
Liu, Yang
Zhang, Suoming
Zhou, Yasheen
Plattner, Jacob J.
Baker, Stephen J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (08) : 2993 - 2996
[47] Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors
Mittapalli, Gopi Kumar
Jackson, Andrew
Zhao, Fang
Lee, Haekyung
Chow, Stephine
McKelvy, Jeffrey
Wong-Staal, Flossie
Macdonald, James E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (22) : 6852 - 6855
[48] Tolerability and pharmacokinetics of BILN 2061, a novel HCV serine protease inhibitor, after oral single doses of 5 to 2400 mg in healthy male subjects.
Narjes, H
Yong, CL
Stähle, H
Steinmann, G
HEPATOLOGY, 2002, 36 (04) : 363A - 363A
[49] A continuous spectrophotometric assay for the hepatitis C virus serine protease
Zhang, RM
Beyer, BM
Durkin, J
Ingram, R
Njoroge, FG
Windsor, WT
Malcolm, BA
ANALYTICAL BIOCHEMISTRY, 1999, 270 (02) : 268 - 275
[50] A continuous spectrophotometric assay for the hepatitis C virus serine protease
Schering-Plough Research Institute, Kenilworth, NJ 07033, United States
Anal. Biochem., 2 (268-275):

← 1 2 3 4 5 →